{"id":71799,"date":"2025-09-10T15:51:37","date_gmt":"2025-09-10T13:51:37","guid":{"rendered":"https:\/\/winback-academy.org\/?post_type=ressources&p=71799"},"modified":"2025-10-02T15:50:13","modified_gmt":"2025-10-02T13:50:13","slug":"etude-retrospective-2022-a-2025-efficacite-et-securite-de-la-back4-dans-la-prise-en-charge-de-la-douleur","status":"publish","type":"ressources","link":"https:\/\/winback-academy.org\/fr\/ressources\/etude-retrospective-2022-a-2025-efficacite-et-securite-de-la-back4-dans-la-prise-en-charge-de-la-douleur\/","title":{"rendered":"\u00c9tude r\u00e9trospective (2022 \u00e0 2025)\u00a0: efficacit\u00e9 et s\u00e9curit\u00e9 de la BACK4 dans la prise en charge de la douleur."},"content":{"rendered":"\n

Une \u00e9tude r\u00e9trospective men\u00e9e entre janvier 2022 et mai 2025 a \u00e9valu\u00e9 l\u2019utilisation du dispositif BACK4<\/strong>, combinant la th\u00e9rapie TECAR (haute fr\u00e9quence), Hi-TENS (haute fr\u00e9quence puls\u00e9e en basse fr\u00e9quence) et la stimulation musculaire Hi-EMS (moyenne fr\u00e9quence), dans le traitement de douleurs aigu\u00ebs et chroniques. L\u2019objectif principal \u00e9tait de mesurer son efficacit\u00e9 sur la r\u00e9duction de la douleur, ainsi que sa tol\u00e9rance en pratique clinique.<\/p>\n\n\n\n

M\u00e9thodologie<\/strong><\/h2><\/div>\n\n\n\n
    \n
  • Type d\u2019\u00e9tude :<\/strong> observationnelle, non interventionnelle.<\/li>\n\n\n\n
  • Population :<\/strong> 89 patients (50 femmes, 39 hommes), \u00e2ge moyen 46,6 ans.<\/li>\n\n\n\n
  • Indications principales :<\/strong> lombalgies (21 %), traumatismes ou chirurgies du genou (20 %), tendinopathies (16 %), troubles musculosquelettiques (13 %), autres pathologies inflammatoires et traumatiques.<\/li>\n<\/ul>\n\n\n\n

    Table 1.<\/strong> General characteristics of patients (N = 89)<\/p>\n\n\n\n

    Variables<\/th>Data<\/th><\/tr><\/thead>
    Female<\/td>50<\/td><\/tr>
    Male<\/td>39<\/td><\/tr>
    Age (y)<\/td>46.6 \u00b1 17.3 (range 18 \u2013 87)<\/td><\/tr>
    Common indications treated<\/td><\/td><\/tr>
    \u2022 Acute and chronic low back pain<\/td>21 %<\/td><\/tr>
    \u2022 Knee trauma and post-surgical knee surgery<\/td>20 %<\/td><\/tr>
    \u2022 Tendinopathy<\/td>16 %<\/td><\/tr>
    \u2022 Musculoskeletal disorders<\/td>13 %<\/td><\/tr>
    \u2022 Inflammatory pathologies<\/td>8 %<\/td><\/tr>
    \u2022 Sprains<\/td>7 %<\/td><\/tr>
    \u2022 Fractures<\/td>6 %<\/td><\/tr>
    \u2022 Pelvic floor and abdominal pain<\/td>4 %<\/td><\/tr>
    \u2022 Shoulder dislocation<\/td>4 %<\/td><\/tr><\/tbody><\/table>
    Values are presented as mean \u00b1 standard deviation, number and percentage.<\/figcaption><\/figure>\n\n\n\n
    <\/div>\n\n\n\n
      \n
    • Protocole :<\/strong> en moyenne 8 s\u00e9ances de 25 minutes, \u00e0 raison de 2 \u00e0 3 s\u00e9ances par semaine, r\u00e9alis\u00e9es par des kin\u00e9sith\u00e9rapeutes.<\/li>\n<\/ul>\n\n\n\n

      R\u00e9sultats<\/strong><\/h2><\/div>\n\n\n\n
        \n
      • Douleur :<\/strong> nette am\u00e9lioration, avec un score EVA moyen passant de 4,0 \u00e0 0,8 au repos<\/strong> et de 7,0 \u00e0 1,2 en mouvement<\/strong> (p<0,0001).<\/li>\n<\/ul>\n\n\n\n

        Table 2.<\/strong> Mean VAS scores at rest and while moving<\/p>\n\n\n\n

        Variables<\/th>Baseline<\/th>After total sessions<\/th>p-value<\/th><\/tr><\/thead>
        VAS score at rest<\/td>4.0 \u00b1 2.4<\/td>0.8 \u00b1 1.3<\/td><0.0001<\/td><\/tr>
        VAS score while moving<\/td>7.0 \u00b1 1.9<\/td>1.2 \u00b1 1.5<\/td><0.0001<\/td><\/tr><\/tbody><\/table>
        Values are presented as mean \u00b1 standard deviation.<\/figcaption><\/figure>\n\n\n\n
        <\/div>\n\n\n
        \n
        \"\"<\/figure>\n<\/div>\n\n\n

        Figure 1.<\/strong> Mean VAS scores. ****p<0.0001<\/p>\n\n\n\n

        <\/div>\n\n\n\n
          \n
        • Mobilit\u00e9 :<\/strong> am\u00e9lioration fonctionnelle significative :\n
            \n
          • Flexion du genou : de 80,3\u00b0 \u00e0 115,3\u00b0<\/strong> apr\u00e8s traitement (p<0,0001).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n

            Table 3.<\/strong> Mean Knee flexion in degrees<\/p>\n\n\n\n

            Variables<\/th>Baseline<\/th>After total sessions<\/th>p-value<\/th><\/tr><\/thead>
            Knee flexion (\u00b0)<\/td>80.3 \u00b1 22.0<\/td>115.3 \u00b1 16.3<\/td><0.0001<\/td><\/tr><\/tbody><\/table>
            Values are presented as mean \u00b1 standard deviation.<\/figcaption><\/figure>\n\n\n\n
            <\/div>\n\n\n
            \n
            \"\"<\/figure>\n<\/div>\n\n\n
              \n
            • Test de Schober pour les lombalgies : am\u00e9lioration statistiquement significative (p<0,001).<\/li>\n<\/ul>\n\n\n\n

              Table 4.<\/strong> Schober\u2019s test in centimeters<\/p>\n\n\n\n

              Variables<\/th>Baseline<\/th>After total sessions<\/th>p-value<\/th><\/tr><\/thead>
              Schober\u2019s test (cm)<\/td>33.3 \u00b1 18.7<\/td>3.8 \u00b1 5.7<\/td>0.0008<\/td><\/tr><\/tbody><\/table>
              Values are presented as mean \u00b1 standard deviation.<\/figcaption><\/figure>\n\n\n\n
              <\/div>\n\n\n
              \n
              \"\"<\/figure>\n<\/div>\n\n\n
                \n
              • Qualit\u00e9 de vie (SF-36, n=26) :<\/strong> progression de 81,0 \u00e0 87,2 points<\/strong> (p=0,001).<\/li>\n\n\n\n
              • Prise m\u00e9dicamenteuse :<\/strong> chute de 70,8 % des patients \u00e0 seulement 5,6 % (p<0,0001).<\/li>\n<\/ul>\n\n\n\n

                Table 6.<\/strong> Medication intake<\/p>\n\n\n\n

                Variables<\/th>Baseline<\/th>After total sessions<\/th>p-value<\/th><\/tr><\/thead>
                Medication intakea<\/sup>, n (%), n = 89<\/td>63 (70.8)<\/td>5 (5.6)<\/td><0.0001<\/td><\/tr><\/tbody><\/table>
                <\/sup>Binary variables (yes vs no), Values are presented as number (percentage).<\/figcaption><\/figure>\n\n\n\n
                <\/div>\n\n\n\n
                  \n
                • <\/li>\n<\/ul>\n\n\n
                  \n
                  \"\"<\/figure>\n<\/div>\n\n\n

                  S\u00e9curit\u00e9 :<\/strong> aucun effet ind\u00e9sirable ni incident rapport\u00e9. La tol\u00e9rance a \u00e9t\u00e9 excellente.<\/p>\n\n\n\n

                  Conclusion<\/strong><\/h2><\/div>\n\n\n\n

                  Cette \u00e9tude r\u00e9trospective sur 89 patients durant environ 3 ans confirme que le dispositif BACK4 est s\u00fbr et efficace<\/strong> dans le traitement de douleurs musculosquelettiques vari\u00e9es. Il permet une r\u00e9duction significative de la douleur<\/strong>, une am\u00e9lioration de la mobilit\u00e9 et de la qualit\u00e9 de vie<\/strong>, tout en r\u00e9duisant le recours aux m\u00e9dicaments<\/strong>.<\/p>\n\n\n\n

                  Les auteurs soulignent toutefois les limites li\u00e9es \u00e0 l\u2019absence de groupe contr\u00f4le et \u00e0 l\u2019h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 des indications.<\/p>\n\n\n\n

                  <\/p>\n","protected":false},"author":27,"featured_media":71823,"template":"","cat_ressource":[705],"technology":[707],"device":[],"field_of_application":[],"pathology":[],"body_part":[],"language":[817],"type_of_content":[],"class_list":["post-71799","ressources","type-ressources","status-publish","has-post-thumbnail","hentry","cat_ressource-clinical-studies-fr","technology-tecartherapie","language-french-fr","pmpro-has-access"],"acf":[],"_links":{"self":[{"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/ressources\/71799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/ressources"}],"about":[{"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/types\/ressources"}],"author":[{"embeddable":true,"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/users\/27"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/media\/71823"}],"wp:attachment":[{"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/media?parent=71799"}],"wp:term":[{"taxonomy":"cat_ressource","embeddable":true,"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/cat_ressource?post=71799"},{"taxonomy":"technology","embeddable":true,"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/technology?post=71799"},{"taxonomy":"device","embeddable":true,"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/device?post=71799"},{"taxonomy":"field_of_application","embeddable":true,"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/field_of_application?post=71799"},{"taxonomy":"pathology","embeddable":true,"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/pathology?post=71799"},{"taxonomy":"body_part","embeddable":true,"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/body_part?post=71799"},{"taxonomy":"language","embeddable":true,"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/language?post=71799"},{"taxonomy":"type_of_content","embeddable":true,"href":"https:\/\/winback-academy.org\/fr\/wp-json\/wp\/v2\/type_of_content?post=71799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}